What is iRhythm Technologies Book Value per Share?
iRhythm Technologies's book value per share for the quarter that ended in Dec. 2023 was $6.79.
During the past 12 months, iRhythm Technologies's average Book Value Per Share Growth Rate was -14.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -16.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 21.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of iRhythm Technologies was 64.20% per year. The lowest was -16.80% per year. And the median was 16.10% per year.
During the past 10 years, the highest P/B Ratio of iRhythm Technologies was 54.14. The lowest was 4.26. And the median was 15.52.
iRhythm Technologies Book Value per Share Historical Data
The historical data trend for iRhythm Technologies's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of iRhythm Technologies's Book Value per Share
For the Medical Devices subindustry, iRhythm Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRhythm Technologies's PB Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Technologies's PB Ratio distribution charts can be found below:
* The bar in red indicates where iRhythm Technologies's PB Ratio falls into.
iRhythm Technologies Book Value per Share Calculation
iRhythm Technologies's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
iRhythm Technologies (NAS:IRTC) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
iRhythm Technologies Book Value per Share Related Terms
Thank you for viewing the detailed overview of iRhythm Technologies's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
iRhythm Technologies (iRhythm Technologies) Business Description
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio include ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for up to 14 consecutive days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IRTC has been successfully added to your 